The Law Offices of Frank R. Cruz announces an investigation of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis, indicating that the Company has been improperly billing the federal government for $250 million annually. The Company also set the price for its new wound covering, Affinity, "exorbitantly high[,]" which Medicare reimbursed while making the product lucrative for doctors to use through large rebates.

On this news, Organogenesis's stock price fell $1.70, or 14%, to close at $10.35 per share on October 12, 2021.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Organogenesis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211025005343/en/

The Law Offices of Frank R. Cruz Announces Investigation of Organogenesis Holdings Inc. (ORGO) on Behalf of Investors